search icon
      blog search icon

      MNPR Stock Price History and Quote Analysis: Insights for Investors

      Monopar Therapeutics Inc.

      (NASDAQ:MNPR)

      $0.40

      0.04 (9.88%)

      Open: 1:36 PM

      MNPR Stock Price Graph

      • 1D
      • 5D
      • 1M
      • 3M
      • 6M
      • 1Y
      • YTD
      • All

      MNPR Stock Price Today

      Monopar Therapeutics Inc. (MNPR) stock rallied over 18.88% intraday to trade at $0.4042 a share on NASDAQ. The stock opened with a gain of 19.44% at $0.43 and touched an intraday high of $0.45, rising 12.28% against the last close of $0.36. The Monopar Therapeutics Inc. in stock market went to a low of $0.43 during the session.

      MNPR Stock Snapshot

      $0.36

      Prev. Close

      5.96 Million

      Market Cap

      $0.43

      Day Low

      $0.43

      Open

      N/A

      Number of Shares

      $0.45

      Day High

      N/A

      P/E ratio

      -0.71

      EPS (TTM)

      0.57

      Cash Flow per Share

      N/A

      Free Float in %

      0.47

      Book Value

      278682.00

      Volume

      MNPR Stock Price History Chart

      DateOpenHighLowCloseVolume

      Contact Details

      1000 Skokie Boulevard
      Wilmette, IL 60091
      US

      Website:https://www.monopartx.com

      Contact #:847 388 0349

      Company Information

      EmployeesN/A

      Beta0.76

      Sales or RevenueN/A

      5Y Sales Change0.00%

      Fiscal Year EndsDec. 2022

      SectorHealthcare

      IndustryBiotechnology

      About Company

      Monopar Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States. Its lead product candidate in development is Validive, a clonidine hydrochloride mucobuccal tablet that is in Phase 2b/3 clinical trial for the prevention of chemoradiotherapy induced severe oral mucositis in patients with oropharyngeal cancer. The company also engages in developing Camsirubicin, an analog of doxorubicin, which is in Phase 1b clinical trial for the treatment of advanced soft tissue sarcoma; MNPR-101, a urokinase plasminogen activator receptor targeted antibody for the treatment of various cancers; MNPR-101 RIT, a radioimmunotherapeutic based on MNPR-101 for the potential treatment of cancer and severe COVID-19; and MNPR-202, an analog of camsirubicin to potentially treat doxorubicin-and camsirubicin-resistant cancers. Monopar Therapeutics Inc. has collaborations with the Grupo Español de Investigación en Sarcomas for the development of camsirubicin in patients with advanced soft tissue sarcoma; NorthStar Medical Radioisotopes, LLC to develop radio-immuno-therapeutics targeting severe COVID-19; and the Cancer Science Institute of Singapore to evaluate the activity of MNPR-202 and related analogs in various types of cancer. The company was incorporated in 2014 and is headquartered in Wilmette, Illinois.

      Peers

      Frequently Asked Questions

      icon

      What is the current Monopar Therapeutics Inc. (MNPR) stock price?

      Monopar Therapeutics Inc. (NASDAQ: MNPR) stock price is $0.40 in the last trading session. During the trading session, MNPR stock reached the peak price of $0.45 while $0.43 was the lowest point it dropped to. The percentage change in MNPR stock occurred in the recent session was 18.88% while the dollar amount for the price change in MNPR stock was $0.06.

      icon

      MNPR's industry and sector of operation?

      The NASDAQ listed MNPR is part of Biotechnology industry that operates in the broader Healthcare sector. Monopar Therapeutics Inc. , a clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States.

      icon

      Who are the executives of MNPR?

      Dr. Chandler D. Robinson M.B.A., M.D., M.Sc., MBA, MSc
      Co-Founder, Chief Executive Officer, Pres & Director
      Ms. Kim R. Tsuchimoto CPA
      Chief Financial Officer, Sec. & Treasurer
      Ms. Kim R. Tsuchimoto CPA
      CFO, Sec. & Treasurer
      Ms. Kim R. Tsuchimoto CPA
      Chief Financial Officer, Sec., Treasurer & Director

      icon

      How MNPR did perform over past 52-week?

      MNPR's closing price is 0.01% higher than its 52-week low of $0.427 where as its distance from 52-week high of $4.88 is -0.80%.

      icon

      How many employees does MNPR have?

      Number of MNPR employees currently stands at N/A. MNPR operates from 1000 Skokie Boulevard, Wilmette, IL 60091, US.

      icon

      Link for MNPR official website?

      Official Website of MNPR is: https://www.monopartx.com

      icon

      How do I contact MNPR?

      MNPR could be contacted at phone #847 388 0349 and can also be accessed through its website. MNPR operates from 1000 Skokie Boulevard, Wilmette, IL 60091, US.

      icon

      How many shares of MNPR are traded daily?

      MNPR stock volume for the day was 278682.00 shares. The average number of MNPR shares traded daily for last 3 months was 952.53 Thousands.

      icon

      What is the market cap of MNPR currently?

      The market value of MNPR currently stands at $5.96 Million with its latest stock price at $0.40 and N/A of its shares outstanding.